Repligen | RGEN - 销售毛利

股票价格
120.58
每天变化
0.48 0.40%
每月一次
4.75%
每年
-5.25%
Q2 预测
116.82


金融业
股票价格
USD
资产
USD 2.95B
现金及等价物
USD 566.02M
销售成本
USD 94.08M
流动资产
USD 1.14B
流动负债
USD 135.83M
债务
USD 542.21M
EBIT
USD 19.97M
EBITDA
USD 39.54M
员工
1.78K
EPS每股收益
USD 0.49
股本和储备
USD 2.11B
销售毛利
USD 103.83M
债务利息支出
USD 5.5M
利息收入
USD 7.31M
贷款资金
USD 542.21M
市值
USD 6.7B
净收入
USD 13.29M
营业费用
USD 177.95M
营业利润
USD 19.97M
普通股股本
USD 56.33M
PE价格收益
164.06
税前利润
USD 17.11M
销售收入
USD 197.91M
销售和管理费用
USD 74.36M
股票
USD 170.46M
贸易债权人
USD 30.01M
应收帐款人
USD 158.59M


销售毛利 更改 日
Agilent USD 946M 44M 2025-12
Align Technology USD 683.59M 44.39M 2025-12
Bio Techne USD 191.28M 3.16M 2025-12
BioMarin Pharmaceutical USD 713.01M 81.81M 2025-12
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Bruker USD 449.2M 69.8M 2025-12
Charles River Laboratories USD 271.96M 39.43M 2025-12
Danaher USD 3.97B 443M 2025-12
Dentsply International USD 443M 2M 2025-12
General Electric Aerospace USD 3.8B 118M 2025-12
Henry Schein USD 1.06B 37M 2025-12
Illumina USD 759M 26M 2025-12
IQVIA Holdings USD 1.12B 32M 2025-12
Mettler Toledo International USD 675.44M 65.98M 2025-12
Myriad Genetics USD 146.8M 3M 2025-12
OraSure Technologies USD 11.34M 435K 2025-12
Pacific Biosciences Of California USD 15.74M 601K 2025-12
Pfizer USD 3.54B 7.61B 2025-09
Repligen USD 103.83M 3.32M 2025-12
Revvity USD 421.66M 47.06M 2025-12
Standard Biotools USD 11.38M 1.9M 2025-12
Thermo Fisher Scientific USD 4.64B 419M 2025-12
Waters USD 557.42M 97.44M 2025-12
West Pharmaceutical Services USD 303.9M 9.6M 2025-12